Keyphrases
Age-related Macular Degeneration
100%
Intravitreal
100%
Same-day
100%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
100%
Anti-vascular Endothelial Growth Factor Injection
100%
Miller
33%
School of Medicine
33%
Adverse Effects
33%
Risk Factors
33%
Treatment Modalities
33%
Vascular Endothelial Growth Factor
33%
Number of Patients
33%
Adverse Events
33%
Bevacizumab
33%
Rare Complication
33%
Patient's Will
33%
Ranibizumab
33%
Macular Degeneration
33%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
33%
University of Miami
33%
Exudative Macular Degeneration
33%
Medicine and Dentistry
Age Related Macular Degeneration
100%
Vasculotropin
100%
Medicine
20%
Adverse Effect
20%
Adverse Event
20%
Bevacizumab
20%
Macular Degeneration
20%
Ranibizumab
20%
Wet Macular Degeneration
20%
Treatment Modality
20%
Neuroscience
Vascular Endothelial Growth Factor
100%
Age-Related Macular Degeneration
100%
Macular Degeneration
40%
Adverse Effect
20%
Ranibizumab
20%
Bevacizumab
20%
Risk Factor
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Age Related Macular Degeneration
100%
Adverse Event
20%
Bevacizumab
20%
Ranibizumab
20%
Wet Macular Degeneration
20%
Macular Degeneration
20%